Scilla Biotechnologies Limited - Company Profile

It is a financial services public limited company based in New Delhi, Delhi, India, established in 2004.
2004 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Scilla Biotechnologies Limited

Scilla Biotechnologies Limited, a active public limited company, was established on 13 October 2004 in New Delhi, Delhi, India. Engaging in real estate financing within the financial services sector, it holds CIN: U24232DL2004PLC129869. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.

Formerly known as Scilla Biotechnologies Private Limited. Its leadership includes Arun Kumar Sharma (Director), Nupur Singh (Director), Amit Kumar Singh (Director). Its latest AGM occurred on 14 August 2023, with the balance sheet filed on 31 March 2023. It is based at 301,Iiird Floor Balaji Plaza Bhera Enclave Paschim Vihar, New Delhi, Delhi, 110087.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2004PLC129869

  • Registration Number

    129869

  • Incorporation Date

    13 October 2004

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 21 Year, 4 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Scilla Biotechnologies Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Scilla Biotechnologies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Scilla Biotechnologies Limited?
Current Directors
Name Designation Appointment Date Status
Arun Kumar Sharma Director 07 Feb 2008 Current
Nupur Singh Director 13 Oct 2004 Current
Amit Kumar Singh Director 13 Oct 2004 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Scilla Biotechnologies.

Scilla Biotechnologies Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Scilla Biotechnologies revenue growth over time
Scilla Biotechnologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Scilla Biotechnologies?

In 2023, Scilla Biotechnologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Scilla Biotechnologies?

Unlock and access historical data on people associated with Scilla Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Scilla Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scilla Biotechnologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Scilla Biotechnologies
Recent Activity within the Organization
  • Annual General Meeting

    Scilla Biotechnologies Limited last Annual general meeting of members was held on 14 Aug 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Scilla Biotechnologies Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was completed.

  • Director Appointment

    The activity Arun Kumar Sharma was appointed as a Director was appointed as a Director on 07 Feb 2008 & has been associated with this company since 18 years 23 days . was completed.

  • Director Appointment

    Progress on Nupur Singh was appointed as a Director was appointed as a Director on 13 Oct 2004 & has been associated with this company since 21 years 4 months . was documented.

  • Director Appointment

    Amit Kumar Singh was appointed as a Director was appointed as a Director on 13 Oct 2004 & has been associated with this company since 21 years 4 months . was recorded as a recent event.

  • Company Incorporation

    The activity Scilla Biotechnologies Limited was registered on 13 Oct 2004 with Roc Delhi & aged 21 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Scilla Biotechnologies Limited?

The CIN of Scilla Biotechnologies Limited is U24232DL2004PLC129869.

Where is Scilla Biotechnologies Limited headquartered?

Scilla Biotechnologies Limited is headquartered at 301,Iiird Floor Balaji Plaza Bhera Enclave Paschim Vihar, New Delhi, Delhi, 110087.

When was Scilla Biotechnologies Limited incorporated?

Scilla Biotechnologies Limited was incorporated on 13 October 2004.

Who are the current directors of Scilla Biotechnologies Limited?

The current directors of Scilla Biotechnologies Limited are

What is the primary industry of Scilla Biotechnologies Limited?

The primary industry of Scilla Biotechnologies Limited is Financial Services.

Is Scilla Biotechnologies Limited a listed company?

Scilla Biotechnologies Limited is unlisted.

What is the capital structure of Scilla Biotechnologies Limited?

The authorized capital of Scilla Biotechnologies Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available